P09 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pacific Biosciences of California Inc

Watchlist Manager

Watchlist

Price: 1.4508 EUR Market Closed

Market Cap: €3.9B

P	Pacific Biosciences of California Inc XBER:P09	US
C	Comba Telecom Systems Holdings Ltd XMUN:COA1	HK
J	Jones Lang LaSalle Inc F:4J2	US
A	Active Biotech AB publ SWB:BTPC	SE

Profitability Summary

Pacific Biosciences of California Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

31%

Sustainable 3Y Average Gross Margin

28%

Declining Gross Margin

36% > 31%

Negative Operating Margin

-104%

Negative 3Y Average Operating Margin

-165%

Operating Margin is Increasing

-239% > -104%

Negative Net Margin

-341%

Negative 3Y Average Net Margin

-252%

Declining Net Margin

-239% > -341%

Negative Free Cash Flow Margin

-74%

Negative 3Y Average Free Cash Flow Margin

-135%

Free Cash Flow Margin is Increasing

-221% > -74%

Negative ROE

-213%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-33%

Declining ROIC

-33% > -42%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.